Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cell Based Delivery receives NIST grant for cardiovascular program

Jan. 3, 2000

Benzofurans with cardioprotective, anxiolytic activity designed at Egis

Dec. 30, 1999

Potent, nonpeptide angiotensin II receptor antagonists discovered at Chinese university

Dec. 30, 1999

AstraZeneca seeks approval of Atacand HCT in the U.S.

Dec. 30, 1999

Schwarz, ARYx team up to design novel antiarrhythmic drugs

Dec. 30, 1999

CytRx announces Flocor phase III results

Dec. 28, 1999

Opioid receptor ligands from Novo Nordisk useful for vasomotor disturbances

Dec. 27, 1999

Scios's new p38 MAP kinase inhibitors especially useful for cardiovascular disorders

Dec. 27, 1999

Cardioprotective efficacy of NHE-1 inhibitor is superior to that of IPC

Dec. 27, 1999

Myogen achieves financing for oral enoximone pivotal trial

Dec. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...